glp 1 seizures GLP-1 drugs linked to reduced risk of epilepsy Association Between GLP-1 Receptor Agonist

Jangam, G

Understanding how semaglutide affects blood pressure helps patients and clinicians optimize treatment safety and cardiovascular outcomes during therapy

While patient preference is clearly shifting toward non-injectable options, injectables are projected to retain a 75% market share by 2035, not the minority

The NDC goes on the J-code line item, not on the 96372 line

The flat monthly pricing modelsemaglutide injection at $189/mo (or $149/mo on the 6-month plan)remains consistent whether a patient starts at 0.25 mg or titrates to 2.4 mg over several months

doi: 10.1136/gutjnl-2017-315084 93 HuangHRenZGaoXHuXZhouYJiangJet al